Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Exagen Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 41 | 38 | −3 |
| Shares | 6.11M | 6.24M | +123.9K (+2.0%) |
| Value | $25.1M | $22.4M | −$2.66M (−10.6%) |
New holders (4)
Institutions that held Exagen Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 166,705 | $598.5K | 0.00% |
| Massar Capital Management, LP | 20,840 | $74.8K | 0.09% |
| Gsa Capital Partners LLP | 12,287 | $44.0K | 0.00% |
| Acadian Asset Management LLC | 6,984 | $25.0K | 0.00% |
Sold out (7)
Institutions that held Exagen Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Wasatch Advisors Inc | 42,975 | $176.2K |
| Creative Planning | 35,500 | $145.6K |
| Millennium Management LLC | 15,862 | $65.0K |
| Virtu Financial LLC | 11,203 | $46.0K |
| Citigroup Inc | 5,582 | $22.9K |
| SBI Securities Co., Ltd. | 5,050 | $20.7K |
| Simplex Trading, LLC | 81 | $0 |